- Home
- PYPD vs JG Comparison
PYPD vs JG Comparison
Compare PYPD & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- JG
- Stock Information
- Founded
- PYPD 2008
- JG 2012
- Country
- PYPD Israel
- JG China
- Employees
- PYPD N/A
- JG N/A
- Industry
- PYPD Medical/Dental Instruments
- JG Computer Software: Programming Data Processing
- Sector
- PYPD Health Care
- JG Technology
- Exchange
- PYPD Nasdaq
- JG Nasdaq
- Market Cap
- PYPD 54.7M
- JG 48.4M
- IPO Year
- PYPD 2020
- JG 2018
- Fundamental
- Price
- PYPD $3.80
- JG $7.84
- Analyst Decision
- PYPD Strong Buy
- JG
- Analyst Count
- PYPD 5
- JG 0
- Target Price
- PYPD $12.00
- JG N/A
- AVG Volume (30 Days)
- PYPD 92.7K
- JG 6.9K
- Earning Date
- PYPD 11-12-2025
- JG 11-13-2025
- Dividend Yield
- PYPD N/A
- JG N/A
- EPS Growth
- PYPD N/A
- JG N/A
- EPS
- PYPD N/A
- JG N/A
- Revenue
- PYPD N/A
- JG $48,999,972.00
- Revenue This Year
- PYPD N/A
- JG $10.90
- Revenue Next Year
- PYPD N/A
- JG N/A
- P/E Ratio
- PYPD N/A
- JG N/A
- Revenue Growth
- PYPD N/A
- JG 18.82
- 52 Week Low
- PYPD $2.30
- JG $4.25
- 52 Week High
- PYPD $3.93
- JG $20.94
- Technical
- Relative Strength Index (RSI)
- PYPD 68.11
- JG 37.37
- Support Level
- PYPD $3.10
- JG $8.08
- Resistance Level
- PYPD $3.50
- JG $8.55
- Average True Range (ATR)
- PYPD 0.18
- JG 0.28
- MACD
- PYPD 0.06
- JG 0.00
- Stochastic Oscillator
- PYPD 94.87
- JG 27.73
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.